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ttp://dx.doi.org/10.1016/j.ajpath.2014.02.028Apoptosis is the most widely recognized form of physiological programmed cell death. During the past
three decades, various nonapoptotic forms of cell death have gained increasing attention, largely because
of their potential importance in pathological processes, toxicology, and cancer therapy. A recent addition
to the panoply of cell death phenotypes is methuosis. The neologism is derived from the Greekmethuo (to
drink to intoxication) because the hallmark of this form of cell death is displacement of the cytoplasm by
large ﬂuid-ﬁlled vacuoles derived from macropinosomes. The demise of the cell resembles many forms of
necrosis, insofar as there is a loss of metabolic capacity and plasma membrane integrity, without the cell
shrinkage and nuclear fragmentation associated with apoptosis. Methuosis was initially deﬁned in
glioblastoma cells after ectopic expression of activated Ras, but recent reports have described small
molecules that can induce the features of methuosis in a broad spectrum of cancer cells, including those
that are resistant to conventional apoptosis-inducing drugs. This review summarizes the available in-
formation about the distinguishing morphological characteristics and underlying mechanisms of
methuosis. We compare and contrast methuosis with other cytopathological conditions in which accu-
mulation of clear cytoplasmic vacuoles is a prominent feature. Finally, we highlight key questions that
need to be answered to determine whether methuosis truly represents a unique form of regulated cell
death. (Am J Pathol 2014, 184: 1630e1642; http://dx.doi.org/10.1016/j.ajpath.2014.02.028)Supported by NIH grant R01 CA115495 (W.A.M.) and the Harold and
Helen McMaster Endowment (W.A.M.).
Disclosures: None declared.Commencing with the ﬁrst descriptions of programmed cell
death approximately 50 years ago, intensive research efforts
have focused on classifying cell death pathways and
deﬁning their underlying mechanisms.1 The most widely
recognized form of programmed cell death is apoptosis.
Signature morphological features associated with apoptotic
cell death include plasma membrane blebbing, shrinkage of
the cytoplasm, nuclear chromatin condensation, and even-
tual fragmentation of the cell to form apoptotic bodies.2,3
Apoptotic signaling pathways converge on the mitochon-
dria, where changes in membrane permeability lead tostigative Pathology.
.release of molecules that activate a cascade of cysteine-
dependent aspartate-directed proteases (caspases).4 For this
reason, apoptosis is often considered to be synonymous with
caspase-dependent cell death. However, it is now clear
that other proteins released by damaged mitochondria
(eg, apoptosis-inducing factor, endonuclease G) can also
contribute to apoptosis.5,6
Methuosis: New Nonapoptotic Cell DeathMany forms of nonapoptotic (caspase-independent) cell
death have been described.7 The distinguishing character-
istics are often morphological, but in some instances, there
has been enough progress to permit the use of biochemical
and functional criteria to deﬁne distinct cell death sub-
routines. On the basis of such considerations, the Nomen-
clature Committee on Cell Death has recognized nine
regulated cell death modes in addition to intrinsic or
extrinsic apoptosis.7 Some of these forms of cell death, such
as anoikis, are triggered by unique signals (detachment of
adherent cells from the extracellular matrix) but share
essentially the same execution pathways as apoptosis.8
Others, such as netosis (granulocytes)9 and corniﬁcation
(keratinocytes),10 occur only in speciﬁc cell types. However,
several nonapoptotic cell death subroutines appear to have
much broader pathophysiological relevance.
One of the most widely studied alternatives to apoptosis is
autophagic cell death, known for many years as type 2 cell
death (versus type 1 for apoptosis).11,12 In autophagic cell
death, autophagosomes and autophagolysosomes accumulate
in the cytoplasmic compartment of the affected cells. Unabated
autophagy (self-eating) of proteins and organelles is believed
to precipitate the eventual loss of cell viability. Controversy
stems from the fact that autophagy is also recognized as a
mechanism to promote cell survival in the face of nutrient
deprivation, genomic damage, or oxidative stress.13,14 There-
fore, in some reported cases of autophagic cell death, the
accumulation of autophagosomes may represent an adaptive
response to stress, rather than a direct cause of cell death.7
Other forms of cell death that occur in a broad spectrum
of cell types appear to fall within the general category of
programmed or regulated necrosis.15 Examples include
necroptosis16 and parthanatos.17 In contrast to the long held
view of necrosis as a passive or accidental cytolytic process
provoked by cell injury or metabolic catastrophe,18 these
forms of cell death are initiated through deﬁned signaling
pathways. For instance, necroptosis is triggered by activa-
tion of receptor interacting protein (RIP)1 and/or RIP3
kinases, and can be blocked by a speciﬁc inhibitor, necros-
tatin.19 Parthanatos is induced by activation of poly (ADP-
ribose) polymerase (PARP)-1,20 and thus can be ameliorated
with the use of PARP inhibitors.
The previously mentioned cell death subroutines have
been established as having pathophysiological relevance.
That is, they occur in vivo and play roles in either normal
developmental tissue remodeling or the responses of cells
and tissues to one or more disease processes. Excluded from
the list of cell death mechanisms recognized in the last re-
view by the Nomenclature Committee on Cell Death are
several distinctive cell death phenotypes that have thus far
been conﬁrmed mainly in cells that have been manipulated
genetically or pharmacologically in vitro, or in tissues that
have been exposed to ischemic injury, cytotoxic com-
pounds, or pathogens. Among these, paraptosis,21,22 onco-
sis,23 and methuosis (the subject of this review) are
characterized by swelling or vacuolization of speciﬁcThe American Journal of Pathology - ajp.amjpathol.orgorganelles, necrosis-like membrane disruption, and little or
no responsiveness to caspase inhibitors. Although the
physiological importance of these forms of cell death re-
mains uncertain, they are of signiﬁcant interest in the ﬁelds
of toxicology and cancer therapy. Indeed, in a recent review
of potential anti-cancer agents that promote nonapoptotic
cell death, multiple compounds were featured as inducers of
paraptosis, oncosis, or methuosis.24
Methuosis is one of the most recent additions to the list of
nonapoptotic cell death phenotypes. The name, which is
derived from the Greekmethuo (to drink to intoxication), was
selected because the most prominent attribute in cells
undergoing this form of death is the accumulation of large
ﬂuid-ﬁlled cytoplasmic vacuoles that originate from macro-
pinosomes. In the present review, we begin by recapping the
supporting evidence for classiﬁcation of methuosis as a
distinctive cell death phenotype. We then attempt to place the
recent work on methuosis in the context of the extensive
literature describing vacuolization of cellular endosomal or
lysosomal compartments in response to a variety of toxins
and drugs. Finally, we summarize the current knowledge
about the underlying mechanisms of methuosis and provide a
perspective on the key questions that remain to be addressed.Cytoplasmic Vacuolization and Cell Death
Induced by Activated Ras
Our investigations leading to the identiﬁcation of methuosis as
a novel cell death phenotype were undertaken after a report
from Chi et al,25 in which ectopic expression of an activated
form of the H-Ras oncoprotein (G12 /V) was shown to
induce massive cytoplasmic vacuolization and caspase-
independent cell death in cultured glioblastoma (GBM) and
gastric carcinoma cells. This form of cell death was initially
designated as type 2 (autophagic degeneration). However, as
we began to investigate this phenomenon, we noted that the
morphological characteristics of the vacuoles, induced by
overexpression of Ras, were inconsistent with the morpho-
logical characteristics of autophagosomes or autophagolyso-
somes.26 Speciﬁcally, the vacuoles were phase and electron
lucent, and were bound by a single membrane, rather than the
typical doublemembrane of autophagosomes (Figure 1, A and
C). Analysis of the localization and expression of the auto-
phagosome marker, LC3II, by immunoﬂuorescence micro-
scopy and Western blot analysis revealed that autophagy was,
in fact, elevated in GBM cells expressing Ras(G12V), but the
vesicles labeled with LC3II were smaller and spatially sepa-
rate from the much larger-phase lucent vacuoles. Because
suppression of the autophagy regulatory protein Beclin-1 had
no detectable effect on vacuolization or survival of GBM cells
expressing Ras(G12V), we concluded that elevated autophagy
was a compensatory stress response rather than a cell death
mechanism in this situation.
To identify the origin of the Ras-induced vacuoles, we
performed electron microscopy and ﬂuorescence microscopy1631
Figure 1 Examples of U251 human GBM cells undergoing methuosis triggered by ectopic expression of activated Ras. Conditional expression of H-Ras(G12V)
was induced by addition of doxycycline to a stable cell line (U251-C18). A: The electron micrograph shows the initial stage of methuosis, where large electron-
lucent cytoplasmic vacuoles bound by a single membrane can be seen forming from lamellipodial extensions of the plasma membrane (asterisks). B: The
macropinosome-derived vacuoles remain separate from lysosomes. Lysosomes were prelabeled for 3 hours with LysoTracker Red. Macropinosome-derived vacuoles
were then labeled with dextraneAlexa Fluor 488 (green). The cells were examined 4 hours after addition of the labeled dextran. CeF: Electron micrographs show
detached U251-C18 cells in various stages of degeneration between 4 and 6 days after induction of H-Ras(G12V) expression. Vacuoles accumulate and coalesce
until they ﬁll almost the entire cytoplasmic space. F: The nuclei (N) generally remain intact, with little or no chromatin condensation, even in cells that have
undergone lysis. Images are reprinted with permission from Overmeyer et al.26 Scale bars: 1 mm (A); 10 mm (F).
Maltese and Overmeyerwith ﬂuid-phase tracers andmarkers for endoplasmic reticulum
(ER), mitochondria, endosomes, and lysosomes.26 These
studies demonstrated that the Ras-induced vacuoles did not
emanate from swollen ER membranes or mitochondria, as is
typically the case in paraptosis or oncosis. Instead, we found
that the vacuoles were derived from macropinosomes. Mac-
ropinocytosis is a clathrin-independent endocytic process by
which mammalian cells internalize extracellular ﬂuid, nutri-
ents, and proteins in vesicles (macropinosomes) generated from
protrusions of the plasma membrane termed lamellipodia or
rufﬂes.27 After acquiring phosphatidylinositol-3-phosphate and
the small GTPase, Rab5, macropinosomes enter the endocytic
pathway, where they either recycle back to the cell surface or
mature to acquire characteristics of late endosomes [eg, lyso-
some associated membrane protein (LAMP)1 and Rab7] and
ultimately fuse with lysosomes.28,29 In GBM cells over-
expressing Ras(G12V), macropinocytosis is stimulated, and
large vacuoles can be seen forming from lamellipodial pro-
jections (Figure 1A). However, the macropinocytotic process is
dysfunctional,26 because the nascent macropinosomes, labeled
with ﬂuorescent dextran, do not recycle or fuse with lysosomes
(Figure 1B). Instead, they coalesce to form progressively larger
vacuoles. The latter acquire both LAMP1 andRab7, but are not
sufﬁciently acidic to sequester lysosomotropic dyes, such as
LysoTracker or acridine orange.26 As vacuoles of increasing1632size ﬁll the cytoplasmic space, the cells detach from the sub-
stratum and losemembrane integrity in amanner reminiscent of
necrosis (Figure 1, CeF). However, no protection is afforded
by necrostatin, distinguishing this form of cell death from
necroptosis. In conjunction with the loss of cell viability, some
features common to the execution program of apoptosis can be
detected. These include activation of caspase-3 and cleavage of
caspase substrates, PARP, and lamin A/C.26 Nevertheless, loss
of cell viability is not prevented by the broad-spectrum caspase
inhibitor, z-VAD-fmk, and the typical morphological features
of apoptosis (cell shrinkage, chromatin condensation, and
plasma membrane blebbing) are generally absent (Figure 1,
CeF). Given the poor ﬁt of this phenotype with previously
described forms of nonapoptotic cell death, and its peculiar
association with extreme vacuolization of macropinosome-
derived endosomal compartments, we believed that the
assignment of a unique descriptive name to the process (ie,
methuosis) was warranted.26
Although initial efforts to deﬁne the mechanism of
methuosis focused on stable U251 GBM cells with
H-Ras(G12V) under the control of an inducible promoter,
vacuolization and cell death can be triggered by ectopic
expression of Ras(G12V) in a variety of other cancer cell
lines, including eight genotypically distinct human GBM cell
lines,26 U2OS osteosarcoma cells,30 andMKN-1 and TMK-1ajp.amjpathol.org - The American Journal of Pathology
Methuosis: New Nonapoptotic Cell Deathgastric carcinoma cells.25 Interestingly, there is some
evidence that the potential for cellular vacuolization and
disintegration in response to constitutively activated Ras may
extend to lower eukaryotic organisms. For example, For-
twendel et al31 recently noted that replacement of wild-type
rasA with a dominant-active rasA allele in the ﬁlamentous
fungus, Aspergillus fumigatus, caused excessive vacuolar
expansion reminiscent of methuosis, with swelling and
spontaneous lysis of hyphal compartments. Even so, this
cellular response is at odds with the large body of evidence
indicating that activated forms of Ras are oncogenic. Indeed,
not all cell types respond to ectopic expression of activated
Ras by undergoing extreme vacuolization.25,26,32 As dis-
cussed in the next section, we are beginning to understand
some of the factors that determine whether constitutive
activation of Ras will exert typical oncogenic activity or
anomalous cytotoxicity under particular circumstances.Mechanism of Ras-Induced Methuosis
Ras GTPases (H-, K-, and N-Ras) have long been known to
function as molecular switches in signaling pathways crit-
ical for cell growth and survival. The concept that activating
mutations in Ras are important in tumorigenesis is ﬁrmly
established.33,34 Paradoxically, there is some evidence that
activation of endogenous Ras pathways can promote cell
death instead of cell survival under some circumstances.32,35
In addition to inducing methuosis, overexpression of acti-
vated forms of Ras can trigger apoptosis36,37 and auto-
phagy.38 The balance between the prosurvival and prodeath
functions of Ras depends on factors such as the relative
abundance and subcellular localization of functionally
distinct Ras isoforms, the constellation of upstream re-
ceptors and nucleotide exchange factors impinging on Ras
in a given cell type, and context-speciﬁc variations in the
status of downstream Ras effector pathways. The general
relationship between Ras signaling and apoptosis has been
reviewed elsewhere.32,35 Herein, we will focus on what is
known about the connection between activated Ras and
the vacuolar cytopathological characteristics observed in
GBM cells.
Our early studies established that induction of vacuoliza-
tion in GBM cells by ectopic expression of activated forms of
H-Ras or K-Ras4B does not depend on the best known Ras
effector pathways: the Raf/mitogen-activated protein
kinase/extracellular signaleregulated kinase (ERK)/ERK
cascade, the phosphatidylinositol 3-kinase/Akt pathway,
or the RalGDS/RalA/RalB pathway.39 In seeking other
Ras-dependent mechanisms that could speciﬁcally affect
vesicular trafﬁcking, we were cognizant of reports indicating
the following: i) Ras activation can stimulate macro-
pinocytosis,40,41 ii) a relatedGTPase, Rac1, serves as a positive
mediator of actin assembly required for macropinocytosis,42
and iii) Ras can stimulate guanine-nucleotide exchange
factors that promote activation of Rac1.43 Combining theseThe American Journal of Pathology - ajp.amjpathol.orgobservations, we hypothesized that sustained high-level
expression of Ras(G12V) and consequent chronic stimula-
tion of Rac1 might contribute to the extreme vacuolization
associated with methuosis. The studies of Bhanot et al30
support this model. They show that when the threshold
of ectopic Ras(G12V) expression exceeds the level required
for maximal activation of the canonical growth-stimulatory
ERK and phosphatidylinositol 3-kinase pathways, the amount
of endogenous Rac1 in the active GTP-bound state increases
and vacuolization occurs. Most important, the expression
of constitutively active Rac1(G12V) mimics the effects of
H-Ras(G12V) in GBM cells, and induction of methuosis by
H-Ras(G12V) can be blocked by EHT1864, a selective in-
hibitor of Rac1.
Although the activation of Rac1 is consistent with the
increase in macropinocytotic activity observed in cells
expressing Ras(G12V), it does not explain the defect in
macropinosome recycling. To address this issue, we
considered the impact of chronic Rac1 activation on another
GTPase, Arf6, which functions in the recycling pathway for
noneclathrin-coated endosomes.44,45 We found that as the
relative amount of active Rac1 increases, there is a corre-
sponding decline in the amount of active Arf6.30 This may
explain the defect in recycling of newly internalized mac-
ropinosomes. The effect of Rac1 on Arf6 appears to be
mediated through a stimulatory interaction between Rac1
and GIT-1, a GTPase-activating protein that facilitates hy-
drolysis of GTP on Arf6.30 Taken together, these ﬁndings
suggest that unrestricted activation of Rac1 by Ras(G12V)
plays a dual role, stimulating the formation of incoming
macropinosomes while simultaneously impeding macro-
pinosome recycling by decreasing the pool of active Arf6.
The resulting accumulation of macropinosomes may pro-
mote abnormal vesicle fusion. In the absence of effective
lysosomal clearance, vacuoles eventually ﬁll the cytoplasm
and compromise cell viability. Little is known about the
molecular basis for the inability of the macropinosome-
derived vacuoles to merge with lysosomes or the speciﬁc
steps that may link cell vacuolization to loss of membrane
integrity. As discussed in the next section, the recent
development of small molecules that can induce methuosis
much more rapidly than manipulation of Ras expression
should provide a more tractable experimental model in
which to address such questions.Methuosis Induced by Indole-Based Chalcones
Methuosis caused by overexpression of Ras(G12V) proceeds
asynchronously over a prolonged period (4 to 8 days) in cell
culture. This makes it difﬁcult to dissect the speciﬁc relation-
ship between vacuolization and cell death. Furthermore, we
were particularly interested in exploring the possibility that
stimulation of this nonconventional cell death pathway might
be used as a strategy to kill cancer cells that are resistant to
apoptosis. To facilitate such studies, we began to seek small1633
Maltese and Overmeyermolecules that could rapidly provoke a cellular phenotype
closely resembling Ras-induced methuosis. In 2011, we
described a synthetic indole-based chalcone 3-(2-methyl-
1H indol-3-yl)-1-(4-pyridinyl)-2-propen-1-one (MIPP),
which caused a striking accumulation of phase-lucent
cytoplasmic vacuoles when applied to U251 GBM cells
and a broad spectrum of other cell lines at low micromolar
concentrations46 (Figure 2A). We subsequently developed a
more potent analog with a 5-methoxy group added to the
indole ring (MOMIPP)47 (Figure 2A). These compounds
induced vacuolization within 4 hours, and the effect was
reversible if the compounds were removed within this time
frame. However, if cells were exposed to MIPP or MOMIPP
for 48 hours, they detached from the substratum and un-
derwent a necrosis-like membrane disruption. By electron
microscopy, the morphological characteristics of the dying
cells were similar to the morphological characteristics we
had previously observed in cells undergoing Ras-induced
methuosis (Figure 2B). Loss of viability was conﬁrmed by
a decline in metabolic activity (MTT) and colony formation.
A nonapoptotic mode of death was supported by the fact
that, although the plasma membrane was disrupted, the
nuclear membrane stayed intact and chromatin remainedFigure 2 Examples of U251 GBM cells undergoing methuosis in response
representative cells at 24 hours after addition of 10 mmol/L MIPP or MOMIPP.
uration abolishes the formation of vacuoles. B: Electron micrographs show the
detached (det) cells exposed to MIPP for 48 hours. The detached cells are mostly
plasma membrane (arrows). Nevertheless, the nuclei (N) remain intact, without
U251 cells expressing GFP-Rab7 are decorated with this late endosomal marker
LC3II, or the recycling endosome marker, Rab11. A small subpopulation of the va
transition state between nascent macropinosomes and mature late endosome-l
et al46 and Trabbic et al50 (copyright 2014 American Chemical Society). Images in
10 mm (B and C).
1634diffuse (Figure 2B). Although there was some evidence of
caspase activation (PARP cleavage), the caspase inhibitor,
zVAD-fmk, did not prevent loss of viability.46 A ﬁnal
indication that cell death occurs through a novel mechanism
came from studies with U251 and MCF7 cell lines selected
for their ability to survive in the presence of high levels of
the DNA-damaging drugs, temozolomide or doxorubicin,
respectively. In these resistant cell lines, MIPP and
MOMIPP induced vacuolization and cell death at concen-
trations comparable to those that were effective in the
parental U251 and MCF7 cell lines.46,47
The origin of the vacuoles induced by the indole-based
chalcones is consistent with methuosis. Time-lapse micro-
scopy performed between 13 and 80 minutes after addition
of MIPP revealed waves of phase-lucent macropinosomes
entering the cells from regions of active membrane rufﬂing.
The nascent macropinosomes rapidly coalesced to form
larger vacuoles that failed to dissipate by recycling or fusing
with lysosomes.46 The origination of the vacuoles from
endocytic vesicles was conﬁrmed by their incorporation of
extracellular Lucifer yellow. Moreover, treatment of cells
with ﬁlipin (a cholesterol binding agent) blocked vacuole
formation, consistent with the essential role of cholesterol-to treatment with novel indole-based chalcones. A: The images show
Slight modiﬁcation of MOMIPP by altering the pyridinyl nitrogen conﬁg-
extreme accumulation of electron-lucent vacuoles in attached (att) and
nonviable (Trypan blue staining), and typically have signiﬁcant gaps in the
the characteristic features of apoptosis. C: Vacuoles induced by MIPP in
. The same vacuoles contain LAMP1, but not the autophagosome marker,
cuoles contains the early endosome marker, EEA1, possibly representing a
ike vacuoles. Images in A are reprinted with permission from Overmeyer
B and C are reprinted with permission from Overmeyer et al.46 Scale bars:
ajp.amjpathol.org - The American Journal of Pathology
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endocytic processes.48,49Mechanism of Methuosis Induced by MIPP and
MOMIPP
Studies with a synthetic library of MIPP and MOMIPP an-
alogs revealed exquisite structural speciﬁcity in the ability of
these molecules to induce vacuolization and cell death. For
example, simply shifting the nitrogen in the pyridinyl moiety
from the para to meta conﬁguration eliminated vacuolization,
growth inhibition, and cytotoxicity47,50 (Figure 2A). This
suggests that the methuosis phenotype induced by these
molecules is probably due to their interaction with one or
more speciﬁc protein targets, rather than non-speciﬁc elec-
trophilic protein modiﬁcation. The identities of the speciﬁc
targets remain to be established, but clues from recent studies
suggest that they could include regulatory or structural
components of the early and/or late endocytic pathways.
Similar to the vacuoles induced by Ras, the MIPP-induced
vacuoles acquire late endosomal markers, Rab7 and LAMP1
(Figure 2C), but remain separate from ER, mitochondria, and
lysosomes.46 Moreover, once established, the vacuoles are
distinct from early endosomes (EEA1), recycling endosomes
(Rab11), and autophagosomes (LC3II) (Figure 2C). Despite
these striking parallels, the effects of MIPP differ from those
induced by Ras in some aspects. First, MIPP-induced cellular
vacuolization evolves over a matter of hours rather than days.
Second, in the MIPP-treated cells, the initial burst of macro-
pinocytotic activity ceases after a few hours as larger vacuoles
accumulate. This could signify that perturbations within the
endocytic pathway ultimately disrupt not only the recycling
and lysosome fusion steps, but also the machinery for
generating new macropinosomes. Finally, the activation states
of Rac1 and Arf6 do not change during the initial period of
MIPP-induced vacuolization.46 This implies that MIPP and
related compounds probably target components of the endo-
cytic apparatus downstream from the steps regulated by Rac1
and Arf6.
In accordwith the foregoing idea, we noted that baﬁlomycin
A1 (Baf-A), an inhibitor of the vacuolar Hþ-ATPase,51
blocked the induction of vacuolization by MIPP.46 This is
similar to what happens in cells exposed toHelicobacter pylori
vacuolating toxin A (VacA), where Baf-A prevents vacuoli-
zation of late endosomes.52 The mechanistic basis for the ef-
fect of Baf-A on MIPP-induced vacuolization remains to be
clariﬁed. In addition to its ability to increase the pH of lyso-
somes53 and interfere with fusion between autophagosomes
and lysosomes,54 Baf-A can disrupt trafﬁcking between early
and late endosomes.55,56 Recent studies suggest that the latter
could be mediated through perturbation of the regulatory cycle
of the Rab5 GTPase.57 Rab5 inﬂuences vesicle fusion, matu-
ration, and recycling in both the clathrin-dependent and
the clathrin-independent endocytic pathways.57,58 Macro-
pinosomes typically recruit Rab5 soon after they are formed, inThe American Journal of Pathology - ajp.amjpathol.orgconcert with changes in their membrane phosphoinositide
composition.41 Activation of Rab5 transiently stabilizes mac-
ropinosomes, whereas dissociation of Rab5 after GTP hy-
drolysis allows recruitment of Rab7 and subsequent fusion
with lysosomes.57 When we quantiﬁed the active GTP-bound
forms of Rab5 and Rab7 in cells treated with MIPP, we
detected a signiﬁcant decline in Rab5-GTP and an increase in
Rab7-GTP.46 Consistent with these observations, the mem-
branes of MIPP-induced vacuoles were decorated with Rab7,
but not Rab5.46 This could indicate that MIPP directly or
indirectly affects components of the Rab5 complex,58,59
potentially destabilizing nascent macropinosomes and allow-
ing premature recruitment of Rab7. The increase in Rab7-GTP
might reﬂect an impairment of Rab7 interaction with its
downstream GTPase-activating protein or effectors, perhaps
related to the inability of the vacuoles to fuse with lysosomes.
The possibility that MIPP exerts pleiotrophic effects at various
points in the endocytic pathway is reinforced by the ﬁnding
that neither constitutively active Rab5 nor dominant-negative
Rab7 was able to prevent vacuolization when expressed in
MIPP-treated cells.46Relationship of Methuosis to Other Cellular
Phenotypes Involving Endosomal Vacuolization
In 1946, Trowell60 described the formation of large watery
vacuoles in the cell cytoplasm in liver, after a period of
anoxia. Since then, numerous reports have documented the
accumulation of clear vacuoles in tissues or cultured cells in
response to a variety of environmental changes or toxic
compounds. In an excellent review, Henics and Wheatley61
traced the historical progression of research on cellular
vacuolization from the early view that this was an artifact of
microscopy or “an adaptive physiological response”pp485 to
the more current concept that “the demise which occurs via
the vacuolation route may, in fact, be a distinct form of cell
death which is difﬁcult to ﬁt into the conventional lytic and
apoptotic modes.”pp485 In his often-cited review of develop-
mental cell death, Clarke11 emphasized distinct cell morpho-
logical characteristics that did not ﬁt with the descriptions
of apoptosis (type 1) and autophagic (type 2) cell death.
Collectively, these were termed nonlysosomal vesiculate
degradation (type 3 cell death), and they typically involved
swelling of organelles and vacuolization of the cytoplasm,
without the nuclear changes associated with apoptosis. It now
seems likely that some of these early descriptions of type 3
cell death may correspond to instances of oncosis, paraptosis,
or necroptosis, where, as noted earlier, cytoplasmic vacuoles
originate from swollen ER or mitochondria. Nevertheless, as
discussed later, the literature is replete with reports of cellular
degeneration, where large vacuoles originate from macro-
pinosomes, endosomes, or lysosomes. This raises a question
as to whether the cell death phenotype we have dubbed
methuosis might be applicable to a range of cytopathological
features in which extreme vacuolization of endolysosomal1635
Maltese and Overmeyercompartments is associated with cell death. In the following
sections, we discuss several examples and comment on po-
tential morphological and mechanistic similarities to methuosis
induced by Ras or the indolyl chalcones.
Ectopic Expression of TrkA
Li et al62 described a novel caspase-independent form of cell
death in medulloblastoma cells, in which ectopically
expressed TrkA receptor tyrosine kinase was stimulated by
nerve growth factor. Cell death involved hyperstimulation
of macropinocytosis and accumulation of large phase-lucent
vacuoles that could be labeled with ﬂuid-phase tracers and
antibodies against LAMP1. As in our studies, cell death was
not prevented by suppression of autophagy. There are some
differences between cells overexpressing TrkA and cells
undergoing Ras- or MIPP-induced cell death. In the latter
case, the vacuoles exhibit late endosome characteristics but
fail to fuse with lysosomes, whereas the vacuoles induced
via stimulation of TrkA retain some ability to merge with
lysosomes. Nevertheless, the overall resemblance of this cell
death phenotype to methuosis is striking.
Meth-Induced Neurotoxicity
In addition to altering the integrity of dopaminergic nerve
terminals and the release of neurotransmitters, metham-
phetamine (Meth) can cause lysosomal alkalinization and
vacuolization of endosomal and lysosomal compartments.63
In recent studies with cultured neuroblastoma cells, Nara
et al64 demonstrated that Meth can induce macropinocytosis
and promote accumulation of large LAMP1-positive cyto-
plasmic vacuoles, culminating in cell death without caspase
activation. As in our studies of methuosis, the Meth-induced
vacuoles incorporated ﬂuid-phase tracers but did not display
markers for autophagosomes or ER. The resemblance to
Ras- and MIPP-induced methuosis was further underlined
by the apparent disruption of endolysosomal trafﬁcking in
Meth-treated cells, as evidenced by impaired processing of
the lysosomal protease, cathepsin-L. Finally, as in Ras-
induced methuosis, formation of the vacuoles was shown
to be dependent on the activation of Ras and Rac1.65
Despite these conspicuous similarities, the Meth-induced
cell death phenotype is not identical to the Ras- and
MIPP-induced phenotypes. For example, in the former,
there is no evidence of caspase activation, whereas in the
latter, caspase activation occurred but was not essential for
cell death. Nevertheless, Meth-induced cell death could be a
form of methuosis.
Organic Amines
A wide variety of tertiary amines (eg, procaine, procaina-
mide, disobutamide, and metoclopramide) and other weakly
basic drugs (eg, ephedrine, atropine, and pilocarpine) can
induce prominent cytoplasmic vacuolization in cultured cells1636and tissues, generally when applied in the millimolar
range.66,67 Vacuolization induced by these compounds is not
uniformly linked to cell death. In some cases, cell prolifera-
tion or migration is affected,68,69 whereas in other cases,
prolonged exposure at high concentrations is associated with
modest cytotoxicity.70 It is generally thought that these
compounds penetrate the cell membrane as nonionized weak
bases, and then become trapped inside acidic organelles when
they are protonated. The resulting high intravesicular drug
concentration causes an inﬂux of water to maintain osmotic
balance, leading to the expansion of clear vacuoles derived
from lysosomes, late endosomes, or trans-Golgi ves-
icles.69e71 Given the key roles of low intravesicular pH and
osmotic swelling in this type of vacuolization, it is not sur-
prising that proton pump inhibitors (eg, Baf-A) and extracel-
lular dehydrating agents (eg, mannitol) can mitigate the
morphological effects of the basic compounds.72 In contrast to
the organic amines, the indolyl and pyridinyl nitrogens in
MIPP andMOMIPP are not predicted to behave as weak bases
at physiological pH. Moreover, vacuolization induced by these
compounds is not inhibited by 200 mmol/L mannitol (J. Over-
meyer, unpublished data). Unlike vacuolization induced by
organic amines, which entails vesicle swelling without coales-
cence, methuosis begins with abnormal fusions of peripheral
macropinosomes and clathrin-independent endosomes. On the
basis of these notable differences, we conclude that
methuosis induced by the indolyl chalcones is mechanisti-
cally distinct from the vacuolization of acidic organelles
induced by millimolar concentrations of organic amines.
H. pylori VacA Toxin
The accumulation of large acidic vacuoles derived from late
endosomes was one of the ﬁrst cytopathological effects
documented for the VacA toxin.52 VacA enters endothelial
cells via a Rac1-dependent, clathrin-independent, endocytic
pathway.73,74 In the late endosomes, VacA oligomers form
anion-selective channels that promote inﬂux of Cl, thereby
stimulating the activity of the Hþ-ATPase and decreasing
the intraluminal pH.75,76 With the subsequent entry, pro-
tonation, and trapping of NH3 and other basic molecules,
osmotic swelling occurs, resulting in the formation of large-
phase lucent vacuoles. In this respect, the swelling of
endosomes induced by VacA is similar to what occurs with
organic amines. Because VacA has pleiotrophic effects
separate from endosomal vacuolization,75,76 including direct
interactions with mitochondria,77,78 the speciﬁc steps that
lead to cell death remain unclear. However, on the basis of
the available information, it seems likely that VacA-induced
cytotoxicity is mechanistically distinct from methuosis.
Therapeutic mAbs
Monoclonal antibodies (mAbs) used for treatment of
lymphoid malignancies, such as the type II anti-CD20 mAb,
tositumomab, have been reported to induce nonapoptotic,ajp.amjpathol.org - The American Journal of Pathology
Methuosis: New Nonapoptotic Cell Deathnonautophagic cell death in human leukemia and lymphoma
cells. This form of cell death was characterized by actin
rearrangement and “gross vacuolization of cytoplasm with
relatively intact nuclei.”79,pp2153 Although the origin of the
vacuoles was not studied in detail, they were presumed to
arise from swelling of lysosomes. This was based on the
ﬁnding that cell deathwas associatedwith release of cathepsin
B from acidic vacuoles and could be averted by addition of a
cathepsin inhibitor. It remains to be determined if methuosis
involves lysosomal membrane permeabilization, but the
characteristic phase-lucent vacuoles in methuosis do not
stain with lysosomotropic agents or substrates for cathepsin
B.46 Thus, the cell death phenotype induced by therapeutic
mAbs appears to be distinct from methuosis.
Vacuolins
Cerny et al80 described a series of triazine-based compounds
termed vacuolins that induced extensive cytoplasmic
vacuolization in HeLa cells and other cell lines. The most
potent of these, vacuolin-1, caused the formation of large
vacuoles with characteristics of early endosomes (EEA1
positive) and smaller vacuoles with features of late endo-
somes or lysosomes (LAMP1 positive). Receptor-mediated
endocytic trafﬁcking and sorting were not affected, but
vacuolin-1 markedly inhibited Caþ-dependent exocytosis of
lysosomes. The authors reported that extensive exposure to
vacuolin-1 (7 to 21 days) did not affect cell viability.
Therefore, despite the notable accumulation of phase-lucent
endosomal vacuoles, the cellular phenotype induced by
vacuolin-1 does not qualify as methuosis.
Topoisomerase II Inhibitor
F14512 is a polyamine-modiﬁed topoisomerase II inhibitor,
which is selectively targeted to cancer cells via the polyamine
transport system.81 It is more potent and tumor selective than
the parent compound, etoposide. Brel et al82 reported that
cytotoxicity of F14512 is not due to apoptosis or autophagy,
but rather the accumulation of numerous multilamellar ve-
sicular bodies and large, electron-lucent (methuosis-like)
vacuoles. Despite the provocative morphological resem-
blance to methuosis, the entry of F14512-treated cancer cells
into a senescent state, detected by b-galactosidase staining,
does not ﬁt the methuosis proﬁle. Moreover, because the
origin of the vacuoles from macropinosomes or endosomes
was not conﬁrmed, it remains possible that the F14512-
induced structures could arise from swelling of ER or mito-
chondria, possibly signifying paraptosis or oncosis. Further
studies will be required to classify this form of cell death.
Anticancer Oligonucleotide Aptamer
AS1411 is a guanine-rich oligodeoxynucleotide that selec-
tively inhibits proliferation and induces death in many types
of cancer cells.83,84 The anticancer activity of AS1411 isThe American Journal of Pathology - ajp.amjpathol.orgrelated, at least in part, to its ability to bind to nucleolin and
alter its subcellular localization.85 Most recently, Reyes-
Reyes et al86 reported that AS1411causes hyperstimulation
of macropinocytosis in cancer cells. This is accompanied by
cell swelling and cytoplasmic vacuolization (P. Bates, per-
sonal communication). Further deﬁnition of the origin of the
vacuoles and their connection to loss of viability in cells
treated with AS1411 will be required to determine whether
this may represent a form of methuosis.
Summary
Table 1 summarizes the features associated with the cell
death phenotype we have termed methuosis, compared with
other recognized forms of nonapoptotic cell death. We
propose that the following criteria can be used to broadly
deﬁne the methuosis phenotype: i) Loss of cell viability is
preceded by extreme cytoplasmic vacuolization, caused by
dysfunctional trafﬁcking of macropinosomes and/or none
clathrin-coated endosomes. Although this may include an
initial acceleration of macropinosome formation, the vacu-
olar cytopathology is primarily related to abnormal coales-
cence of nascent macropinosomes that lack the capacity to
recycle and/or merge with lysosomes. ii) The vacuoles
formed in the early stages of methuosis are decorated with
late endosomal markers (eg, LAMP1 and Rab7), but they
are insensitive to dehydrating agents and do not sequester
acidotropic agents, such as acridine orange or LysoTracker.
These features can help to distinguish methuosis from
endosomal or lysosomal swelling induced by weak bases or
bacterial toxins. iii) Loss of cell viability occurs without the
classic morphological features of apoptosis. For example,
cells swell rather than shrink, plasma membrane blebbing is
absent, and chromatin condensation and nuclear fragmen-
tation do not occur before cell lysis. iv) Protection from
death is not afforded by caspase inhibitors, necrostatin, or
suppression of autophagy genes.
Perspective
Our current working model to describe the underlying
cellular perturbations contributing to methuosis is presented
in Figure 3. A limitation of the model is that it is based
primarily on our own studies with GBM cells expressing
activated Ras or treated with indole-based chalcones.
However, at least some of the mechanistic features may also
apply to previously mentioned cytopathological conditions
characterized by dysfunctional macropinocytosis, as described
by other laboratories.62e64,86 Because the characterization of
methuosis as a novel cell death phenotype is a relatively
recent development, a potential point of controversy centers
on whether it truly represents a unique form of regulated cell
death or just a subtype of necrosis or oncosis. Ultimately, the
resolution of this conundrum will require answers to the
following key questions.1637
Table 1 Features of Methuosis Compared with Other Forms of Nonapoptotic Cell Death























Yes Yes Yes Yes No Yes No Varies
Cell swelling Yes Yes Yes Yes No Yes No No
Membrane blebbing No Yes No No No No No No
Chromatin
condensation
No Yes No Yes Yes Yes Yes Yes (late)





Yes No No No No No Yes Varies
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Yes Yes Yes No No Yes Varies
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permeability
Yes No Yes No No Varies
















Excluded are forms of nonapoptotic death that are tissue speciﬁc (eg, netosis9 and corniﬁcation10) or involve cell-in-cell degradation (eg, entosis90).
Maltese and OvermeyerWhat Is the Connection between Vacuolization and Cell
Death?
At present, we have only a rudimentary understanding of how
the vacuolization of macropinosomal and endosomal com-
partments may be linked to molecular pathways or metabolic
events that ultimately lead to the loss of cellular integrity. In
particular, it remains to be determined whether there is a
direct causal relationship between the accumulation of vac-
uoles and cell death. This is a challenging problem because
compounds that are typically used to block macropinocytosis
or endosomal vacuolization (eg, cytochalasins, amiloride, ﬁl-
ipin, and Baf-A) are themselves cytotoxic when applied for
more than a few hours. At present, the main evidence that
vacuolization contributes to cell death comes from correlative
studies. For instance, in early studies of Ras-induced
methuosis, mutagenesis of the C-terminal farnesylation motif
on Ras(G12V) prevented the induction of vacuolization and
eliminated the cytotoxic effect.39 In more recent studies with a
directed library of MIPP-related compounds, minor structural
alterations that abolished vacuolization also eliminated effects
on cell proliferation and viability.47 Despite this type of cir-
cumstantial evidence, there is reason to suspect that endosomal1638vacuolization, by itself, may not be sufﬁcient to precipitate
nonapoptotic cell death. Compounds such as vacuolin-180 and
procaine66 induce prominent endosomal or lysosomal vacuo-
lization but are not immediately cytotoxic. In some normal cell
lines (human skin ﬁbroblasts or mammary epithelial cells),
MIPP and MOMIPP induce robust vacuolization, but cyto-
toxicity is substantially reduced in comparison to tumor cells.
Recently, we reported that substituting longer hydrocarbons
for the 2-methyl on the MOMIPP indolyl moiety markedly
attenuated cytotoxicity but did not prevent the induction of
vacuolization in GBM cells.50 This suggests that cytotoxicity
of these compounds may be related to a unique combination of
effects on macropinosome/endosome trafﬁcking and other
cellular processes that remain to be deﬁned. Ongoing efforts to
identify the speciﬁc protein targets of compounds that are
active in inducing methuosis should shed light on this
important issue.
What Is the Execution Program in Cells Undergoing
Methuosis?
As noted earlier, cells undergoing extreme vacuolization in
response to activated Ras or treatment withMIPP orMOMIPPajp.amjpathol.org - The American Journal of Pathology
Figure 3 Aworkingmodel ofmethuosis: Nascentmacropinosomesgenerated from lamellipodialmembraneprojections enter the cell andcoalesce to formlargeﬂuid-
ﬁlled vacuoles. The latter are unable to recycle like normal macropinosomes, but rapidly mature to form a stable vacuole population with some characteristics of late
endosomes (Rab7andLAMP1). In contrast to functional late endosomes, thevacuolesdonot sequester acidotropicmarkers (LysoTracker andacridineorange) or fusewith
pre-existing lysosomes. It remains to be determined if the vacuoles have the capacity to disrupt protein trafﬁcking in the clathrin-dependent pathway ormergewith early
endosomes or late multivesicular endosomes. Although there is good evidence that the macropinosome-derived vacuoles are distinct from autophagosomes, it will be
important to determine whether the accumulation of vacuoles or associated changes in themetabolic state of the cell may have an impact onmacroautophagy. A central
question for future study is how vacuolization of macropinosomes or late endosomes leads to loss of membrane integrity and necrotic cell death. Contributing factors,
which are not mutually exclusive, could include compromised mitochondrial energy metabolism, mitochondrial outer membrane permeability (MOMP), lysosomal
membrane permeability (LMP), or ER stress. AIF, apoptosis-inducing factor; Cyt c, cytochrome c.
Methuosis: New Nonapoptotic Cell Deatheventually detach from the substratum and undergo a necrosis-
like disruption of membrane integrity. A decline in ATP is
temporally correlated with cell death.46 Although these events
are suggestive of metabolic catastrophe, this remains to be
proved. Failure of mitochondrial bioenergetic function91 and
release of proteases from damaged lysosomes92,93 are hall-
marks of necrotic cell death, but so far, we know little about
potential changes in mitochondrial or lysosomal membrane
permeability during methuosis. There is some evidence that
disruption of metabolic activity, perhaps reﬂecting altered
mitochondrial function, may be an early event in GBM cells
exposed to MOMIPP. For instance, in an unpublished study,
we observed that the capacity of the vacuolated cells to reduce
MTT to formazan declines by approximately 50% after only 4
hours, whereas loss of cell viability (Trypan blue uptake) is not
detected until 24 to 48 hours. Conversion ofMTT to formazan
reﬂects the activity of succinate and NADH-dependent de-
hydrogenases in mitochondria and other subcellular com-
partments.94,95 Thus, these preliminary observations raise theThe American Journal of Pathology - ajp.amjpathol.orgpossibility that defects in cellular bioenergetics may contribute
to the cellular demise associated with methuosis. As suggested
in Figure 3, changes in energy status might also lead to cell
death via the accumulation of unfolded proteins (ER stress) or
alterations in lysosomal membrane permeability. Further ex-
amination of the relationship between vacuolization and
oxidative metabolism should prove extremely useful for
establishing the basis for the necrotic changes that occur dur-
ing methuosis, as well as the differential sensitivity of normal
versus cancer cells.
What Is the Pathophysiological Relevance of
Methuosis?
We anticipate that recognition of cell death phenotypes
similar or identical to methuosis will increase as more in-
vestigators begin to deﬁne the origins of cytoplasmic vac-
uoles frequently observed in cultured cells treated with
small molecules and toxins. However, an important1639
Maltese and Overmeyerunresolved question is whether methuosis can occur in vivo
in response to intrinsic signals under normal or pathological
conditions. There is no shortage of morphological evidence
for the occurrence of clear nonlysosomal vacuoles in
necrotic cells during developmental tissue remodeling11,96
and in post-mortem tissues from animals exposed to
anoxia,60,97 ischemia,87 or toxic chemicals.98 Although such
observations are often attributed to oncosis, in the absence
of information about the origins of such vacuoles or data to
causally link vacuolization with cell death, it remains
possible that some of these observations might represent
instances of methuosis. Ultimately, the identiﬁcation of
molecular markers or speciﬁc inhibitors of methuosis will be
required to determine whether this form of cell death occurs
in animal tissues. Regardless of the eventual answer to this
question, there is substantial value in continuing to char-
acterize this and other non-physiological modes of cell
death because of their relevance in toxicology,99 and
because of the real prospect that artiﬁcially stimulating such
forms of cell death may be therapeutically useful for treating
cancers in which mutations in tumor-suppressor genes
decrease susceptibility to agents that depend on induction of
classic apoptosis.24,100Note Added in Proof
While this review was in press, Kitambi et al101 published
an article describing a small molecule termed Vacquinol-1,
which induces nonapoptotic cell death characterized by
massive macropinocytosis, catastrophic vacuolization, and
membrane rupture in human glioblastoma cells. We believe
that this form of cell death meets the general criteria for
methuosis summarized herein. In particular, the authors
demonstrate that Vacquinol-1 is able to suppress tumor
growth and prolong survival in an orthotopic xenograft
model of human glioblastoma. This reinforces the concept
that small molecules with the capacity to induce methuosis
may be of considerable interest as potential therapeutics for
cancers that are resistant to apoptosis.References
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